https://www.neurologylive.com/view/potential-fda-accelerated-approval-lgmd2ir9-therapy-douglas-sproule
0
0
9/19/23 at 5:03pm
Organization
Neurologylive.com
The chief medical officer at ML Bio Solutions, an affiliate of BridgeBio, discussed how promising conversations between researchers and regulatory authorities suggest a potential pathway for accelerated approval for limb-girdle muscular dystrophy type 2I/R9. …
Create an account
or login to join the discussion